Skip to main
ZIMV
ZIMV logo

Zimvie (ZIMV) Stock Forecast & Price Target

Zimvie (ZIMV) Analyst Ratings

Based on 5 analyst ratings
Hold
Strong Buy 20%
Buy 0%
Hold 40%
Sell 40%
Strong Sell 0%

Bulls say

ZimVie Inc has demonstrated resilience in a challenging implant market by increasing its market share, which bodes well for future revenue stability. The company's adjustment EBITDA margin improvement to 13.8%, reflecting a year-over-year increase of 250 basis points and surpassing consensus estimates, indicates strong operational efficiency. Additionally, the growth of domestic dental revenue, which outperformed expectations, reinforces the potential for sustained revenue growth in both the dental and spine segments in the coming years.

Bears say

ZimVie Inc. has reported a decline in organic revenue by 0.4% to $117 million, with domestic growth negatively impacted by lower iTero and implant sales, and a projected drop in revenue of 3-4% year-over-year for 3Q24. The company's operating margin decreased to 4.2%, falling 170 basis points year-over-year and significantly below consensus expectations of 7.7%, indicating potential challenges in operational efficiency. Furthermore, lowered earnings per share estimates for 2024 and 2025, combined with depressed dental multiples and declining revenue forecasts, suggest ongoing headwinds that could hamper ZimVie's financial performance.

Zimvie (ZIMV) has been analyzed by 5 analysts, with a consensus rating of Hold. 20% of analysts recommend a Strong Buy, 0% recommend Buy, 40% suggest Holding, 40% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Zimvie and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Zimvie (ZIMV) Forecast

Analysts have given Zimvie (ZIMV) a Hold based on their latest research and market trends.

According to 5 analysts, Zimvie (ZIMV) has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Zimvie (ZIMV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.